Cargando…
Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
Afatinib is an oral tyrosine kinase inhibitor (TKI) that inhibit Endothelial Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and HER4. The common side effects of EGFR TKI are rash, acne, diarrhea, stomatitis, pruritus, nausea, and loss of appetite. Drug induced pneumo...
Autores principales: | Yoo, Sang Hoon, Ryu, Jin Ah, Kim, Seo Ree, Oh, Su Yun, Jung, Gu Sung, Lee, Dong Jae, Kwak, Bong Gyu, Nam, Yu Hyun, Kim, Kyung Hyun, Yang, Young Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Family Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122668/ https://www.ncbi.nlm.nih.gov/pubmed/27900074 http://dx.doi.org/10.4082/kjfm.2016.37.6.351 |
Ejemplares similares
-
A Case of Hypersensitivity Pneumonitis with Giant Cells in a Female Dental Technician
por: Kim, Yong-Hyun, et al.
Publicado: (2013) -
A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
por: Song, Si-Yeon, et al.
Publicado: (2020) -
Fatal Coxsackievirus A-16 Pneumonitis in Adult
por: Legay, François, et al.
Publicado: (2007) -
Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations
por: Chen, Yi-Chieh, et al.
Publicado: (2021) -
Fatal Pneumonitis Induced by Oxaliplatin: Description of Three Cases
por: Pontes, L.B., et al.
Publicado: (2012)